Skip navigation
Speakers

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

September 25-26, 2018
  • Boston, MA

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

Sima Basher
Associate Director,
Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Sabrina Basu
Director, External Reporting,
Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Maggie Berkeley
Director
RSM US LLP

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Chris Cobourn
Managing Director
KPMG

Amy Diebler
Vice President, Finance and Chief Financial Officer
Chiesi USA Inc.

Gisele Dion
Chief Accounting Officer
Shire

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Kim Cobleigh Drapkin
Chief Financial Officer
Jounce Therapeutics, Inc.

Peter Emerling
Director, Technology and Management Consulting
RSM US LLP

David A. Ethridge
U.S. IPO Services Leader, Capital Markets and
Accounting Advisory Services
PwC

Brian Filippini
President
Concord Management Group Int'l

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

Joel Gardosik
Partner
CFG

Mark Gauthier
Managing Director, Accounting for Income Taxes
CFG

Mike Gregorski
Partner, National Director of Risk -
Technical Accounting Consulting
RSM US LLP

Jennifer Kimmel
National Assurance Director
BDO

John Lanza
National Life Sciences Industry Leader
RSM US LLP

David Lewin
Managing Director and Leader of
the New England Accounting Advisory Practice
CBIZ & MHM

Jane Lin
Consultant in the New England Accounting Advisory Practice
CBIZ & MHM

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Federica "Freddi" O'Brien
President, CFO'Brien Consulting, LLC;
former CFO, Barrier Therapeutics, Cardiokine Inc.,
Cervilenz Inc., Cerecor Inc., Complexa Inc.

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Nate Ruey
Partner
RSM US LLP

Kim Susko
Consulting Director
RSM US LLP

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

Sima Basher
Associate Director,
Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Sabrina Basu
Director, External Reporting,
Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Maggie Berkeley
Director
RSM US LLP

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Chris Cobourn
Managing Director
KPMG

Amy Diebler
Vice President, Finance and Chief Financial Officer
Chiesi USA Inc.

Gisele Dion
Chief Accounting Officer
Shire

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Kim Cobleigh Drapkin
Chief Financial Officer
Jounce Therapeutics, Inc.

Peter Emerling
Director, Technology and Management Consulting
RSM US LLP

David A. Ethridge
U.S. IPO Services Leader, Capital Markets and
Accounting Advisory Services
PwC

Brian Filippini
President
Concord Management Group Int'l

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

Joel Gardosik
Partner
CFG

Mark Gauthier
Managing Director, Accounting for Income Taxes
CFG

Mike Gregorski
Partner, National Director of Risk -
Technical Accounting Consulting
RSM US LLP

Jennifer Kimmel
National Assurance Director
BDO

John Lanza
National Life Sciences Industry Leader
RSM US LLP

David Lewin
Managing Director and Leader of
the New England Accounting Advisory Practice
CBIZ & MHM

Jane Lin
Consultant in the New England Accounting Advisory Practice
CBIZ & MHM

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Federica "Freddi" O'Brien
President, CFO'Brien Consulting, LLC;
former CFO, Barrier Therapeutics, Cardiokine Inc.,
Cervilenz Inc., Cerecor Inc., Complexa Inc.

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Nate Ruey
Partner
RSM US LLP

Kim Susko
Consulting Director
RSM US LLP

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio